Found 12 matching trials
Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma PHASE1 Patients have a type of cancer called sarcoma. Because there is no standard...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial
Combination Immunotherapy Targeting Sarcomas PHASE1 The aim of this clinical trial is to assess the feasibility, safety and eff...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas PHASE1 This is an open-label, non-randomized, multicenter Phase 1/2 trial evaluati...
Show More Location
District One Hospital
Learn More & Join Trial
Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas PHASE1 This is a open-Label, dose-escalation study to evaluate the safety, tolerab...
Show More Location
Shanghai General Hospital
Learn More & Join Trial
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02) EARLY_PHASE1 CLIC-YYC-GPNMB-02 is a Single Patient Study (SPS) developed according to th...
Show More Status
Active Not Recruiting
Location
Arthur J.E. Child Comprehensive Cancer Centre
Learn More & Join Trial
CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma EARLY_PHASE1 A single patient study to determine whether GCAR1 is safe and effective for...
Show More Status
Active Not Recruiting
Location
Arthur J.E. Child Comprehensive Cancer Centre
Learn More & Join Trial
A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic Sarcoma PHASE1 The purpose of this study is to see if a new treatment could help patients ...
Show More Status
Active Not Recruiting
Location
Seattle Children's Hospital
Learn More & Join Trial
GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma EARLY_PHASE1 CLIC-YYC-GPNMB-01 is a Single Patient Study (SPS) developed according to th...
Show More Location
Tom Baker Cancer Centre/Arthur J.E. Child Comprehensive Cancer Centre
Learn More & Join Trial
iC9-GD2-CAR-VZV-CTLs/Refractory or Metastatic GD2-positive Sarcoma and Neuroblastoma PHASE1 The purpose of this study is to find the largest safe dose of GD2-T cells (...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial
C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) PHASE1 This study is for patients with neuroblastoma, sarcoma, uveal melanoma, bre...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial